Online citations, reference lists, and bibliographies.
← Back to Search

The Treatment Of Malignant Mesothelioma Of The Pleura: Review Of A 5‐Year Experience, With Special Reference To Radiotherapy

D. Ball, D. G. Cruickshank
Published 1990 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Thirty-eight patients with malignant mesothelioma of the pleura were seen at Peter MacCallum Cancer Institute between 1981 and 1985. In 35 patients presenting with disease confined to one hemithorax, the following treatments were given: radical surgery, 13 patients; radical radiotherapy, 12 patients; palliative radiotherapy, 20 patients; chemotherapy, 9 patients; observation only, 2 patients. Median survival from time of diagnosis for all 38 patients was 9 months, with an estimated 2-year survival rate of 16%. Treatment did not significantly affect survival, although there was an indication that patients having radical surgery did better (median survival 17 months) than those who did not (median survival 9 months) (p = 0.13). Fifteen patients were given radiotherapy with radical intent but only 12 completed treatment (50 Gy). The median survival of the 12 patients completing radiotherapy was 17 months, with an estimated 2-year survival rate of 17%. Two patient deaths were attributable to radical radiotherapy (one radiation hepatitis, one radiation myelopathy). Twenty-one patients received 31 courses of palliative radiotherapy for various symptoms, predominantly pain. The results were assessable for 26 courses, with 17 (65%) being at least partly successful. In conclusion, radiotherapy appears to be ineffective in prolonging survival in malignant mesothelioma of the pleura, but has a useful role in palliation.



This paper is referenced by
10.1016/J.CLON.2007.06.004
The role of radiotherapy in the treatment of malignant pleural mesothelioma in the chemotherapy era.
R. Johnston (2007)
10.1053/SONC.2002.30230
Multimodality treatment of diffuse malignant pleural mesothelioma.
L. Zellos (2002)
10.1023/B:SUPE.0000014815.98056.f6
Contributing authors
S. Devadas (2004)
Mesothelioma: treatment and survival of a patient population and review of the literature.
J. Stathopoulos (2005)
10.3191/THERMALMEDICINE.20.171
Intrathoracic Thermochemoradiotherapy for the Treatment of Locally- Advanced Malignant Pleural Mesothelioma
T. Itazawa (2004)
Frecuencia del mesotelioma maligno. Revisión clínica. Experiencia en el Instituto Nacional de Enfermedades Respiratorias durante 1998-2002
J. V. Caloca (2003)
Scuola di Dottorato in Scienze Fisiopatologiche e neuropsicobiologiche e assistenziali del ciclo della vita - Ciclo XXVIII
Roberto Weinstein (2015)
10.1038/onc.2009.415
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Y. Watanabe (2010)
A Comparison of Diffe rent Treatments for Mesothelioma
Samira Rezaei (2014)
Multimodality approach to malignant pleural mesothelioma.
C. Pala (2010)
10.3779/J.ISSN.1009-3419.2010.01.10
Analysis of the Effect of Radiotherapy on Malignant Pleural Mesothelioma when Given on Adjuvant or Palliative Basis
H. E. Hossieny (2010)
10.1016/S0936-6555(05)80582-5
The role of palliative radiotherapy in malignant mesothelioma.
D. Bissett (1991)
10.1093/ANNONC/MDJ962
Pemetrexed and malignant pleural mesothelioma.
M. Marangolo (2006)
10.1016/J.LUNGCAN.2005.03.031
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience.
M. Muenter (2005)
10.20452/PAMW.1005
European guidelines for the management of malignant pleural mesothelioma
E. Thiel (2010)
10.1081/CNV-120023766
Cisplatin and Irinotecan (CPT-11) for Peritoneal Mesothelioma
D. T. Le (2003)
10.1634/THEONCOLOGIST.12-7-850
Multidisciplinary treatment of malignant pleural mesothelioma.
G. Ceresoli (2007)
10.1016/J.JARE.2011.02.004
European guidelines for the management of malignant pleural mesothelioma
E. Thiel (2011)
10.1016/S0003-4975(96)01228-3
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
10.1097/JTO.0b013e3181f1cf2b
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
10.2217/LMT.15.27
Radiation therapy for malignant pleural mesothelioma
Andrea S. Wolf (2015)
10.1007/978-3-642-72041-3_27
Nichtoperative Behandlung primärer und sekundärer Pleuratumoren
C. Manegold (1991)
10.1016/S0360-3016(02)04151-2
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
A. Ahamad (2003)
10.1097/01.LBR.0000011079.00225.DF
Treatment of Mesotheliomatous Pleural Effusion: Experimental Therapy versus Thoracoscopic Talc Poudrage? Pro: Talc Poudrage Therapy
Y. Aelony (2001)
10.1007/0-387-31056-8_38
Therapy for malignant pleural mesothelioma
H. Pass (2006)
10.1016/S1556-0864(15)30386-5
Bilateral choroidal metastases from mesothelioma.
A. Teh (2006)
10.1634/theoncologist.2010-0185
What is the role of radiotherapy in malignant pleural mesothelioma?
A. Price (2011)
10.1016/j.lungcan.2013.11.004
Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic review.
N. Macleod (2014)
10.1007/978-3-030-16884-1_14
Role of Radiotherapy in Malignant Pleural Mesothelioma
M. Scorsetti (2019)
Explorer What Is the Role of Radiotherapy in Malignant Pleural Mesothelioma ?
A. Price (2017)
10.1016/S1040-8428(96)00231-4
Malignant pleural mesothelioma.
H. Hoogsteden (1997)
10.1093/ANNONC/MDI703
State of the art in mesothelioma.
G. Scagliotti (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar